Assessment of prognostic factors in pediatric adrenocortical tumors: the modified pediatric S-GRAS score in an international multicenter cohort—a work from the ENSAT-PACT working group
European Journal of Endocrinology · 2024
DOI: 10.1093/ejendo/lvae079 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von Maria Riedmeier und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, University Hospital Würzburg, University of Wuerz…. Hauptthemen laut MEDLINE: Adrenal Cortex Neoplasms, Adrenocortical Carcinoma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: IZKF, Dr. Mildred Scheel Stiftung für Krebsforschung, DFG German Research Foundation.
Abstract (Originalsprache)
Objective
Pediatric adrenocortical carcinoma (pACC) is rare, and prognostic stratification remains challenging. We aimed to confirm the prognostic value of the previously published pediatric scoring system (pS-GRAS) in an international multicenter cohort.
Design
Analysis of pS-GRAS items of pACC from 6 countries in collaboration of ENSAT-PACT, GPOH-MET, and IC-PACT.
Methods
We received patient data of the pS-GRAS items including survival information from 9 centers. PS-GRAS score was calculated as a sum of tumor stage (1 = 0; 2-3 = 1; 4 = 2 points), grade (Ki67 index: 0%-9% = 0; 10%-19% = 1; ≥20% = 2 points), resection status (R0 = 0; RX/R1/R2 = 1 point), age (<4 years = 0; ≥4 years = 1 point), and hormone production (androgen production = 0; glucocorticoid-/mixed-/no-hormone production = 1 point) generating 8 scores and 4 groups (1: 0-2, 2: 3-4, 3: 5, 4: 6-7). Primary endpoint was overall survival (OS).
Results
We included 268 patients with median age of 4 years. The analysis of the pS-GRAS score showed a significantly favorable prognosis in patients with a lower scoring compared to higher scoring groups (5-year OS: Group 1 98%; group 2 87% [hazard ratio {HR} of death 3.6, 95% CI of HR 1.6-8.2]; group 3 43% [HR of death 2.8, 95% CI 1.9-4.4]; group 4: OS 18% [HR of death 2.1, 95% CI 1.7-2.7]). In the multivariable analysis, age (HR of death 3.5, 95% CI 1.8-7.0), resection status (HR of death 5.5, 95% CI 2.7-11.1), tumor stage (HR of death 1.9, 95% CI of HR 1.2-3.0), and Ki67 index (HR of death 1.7, 95% CI 1.2-2.4) remained strong independent outcome predictors. Especially infants < 4 years showed more often low-risk constellations with a better OS for all tumor stages.
Conclusion
In an international multicenter study, we confirmed that the pS-GRAS score is strongly associated with overall survival among patients with pACC. Age, resection status, stage, and Ki67 index are important parameters for risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, University Hospital Würzburg, University of Wuerzburg, Josef-Schneiderstr. 2, 97080 Wuerzburg, Germany.
- KIONET, The Phase I/II Pediatric Oncology Network Bavaria, 91054 Erlangen, Germany.
- Department of Pathology, All India Institute of Medical Sciences, New Delhi 110029, India.
- Department of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Sao Paulo 14051-200, Brazill.
- Hospital Infantil Joana Gusmão, Department of Pediatrics, 152 Rui Barbosa St., Florianópolis, SC 88025-300, Brazil.
- Department of Pediatric Oncology, Hacettepe University Faculty of Medicine, 06100 Ankara, Turkey.
ORCID-Profile: Maria Riedmeier, Martin Fassnacht, Tulay Guran, Michaela Kuhlen, Antje Redlich, Soraya Puglisi
Förderung
- IZKF
- Dr. Mildred Scheel Stiftung für Krebsforschung
- DFG German Research Foundation
Zitieren
APA
Riedmeier, M., Agarwal, S., Antonini, S., Costa, T. E. I. J. B., Diclehan, O., Fassnacht, M., Figueiredo, B. C., Guran, T., Härtel, C., Haubitz, I., Idkowiak, J., Kuhlen, M., Noronha, L., Parise, I. Z. S., Redlich, A., Puglisi, S., Saniye, E., Schlegel, P. G., Yalcin, B., & Wiegering, V. (2024). Assessment of prognostic factors in pediatric adrenocortical tumors: the modified pediatric S-GRAS score in an international multicenter cohort—a work from the ENSAT-PACT working group. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae079
Vancouver
Riedmeier M, Agarwal S, Antonini S, Costa TEIJB, Diclehan O, Fassnacht M, et al. Assessment of prognostic factors in pediatric adrenocortical tumors: the modified pediatric S-GRAS score in an international multicenter cohort—a work from the ENSAT-PACT working group. European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae079
BibTeX
@article{Riedmeier2024,
author = {Riedmeier, Maria and Agarwal, Shipra and Antonini, Sonir and Costa, Tatiana E I Jaick B and Diclehan, Orhan and Fassnacht, Martin and Figueiredo, Bonald C and Guran, Tulay and Härtel, Christoph and Haubitz, Imme and Idkowiak, Jan and Kuhlen, Michaela and Noronha, Lúcia and Parise, Ivy Zortéa S and Redlich, Antje and Puglisi, Soraya and Saniye, Ekinci and Schlegel, Paul-Gerhardt and Yalcin, Bilgehan and Wiegering, Verena},
title = {Assessment of prognostic factors in pediatric adrenocortical tumors: the modified pediatric S-GRAS score in an international multicenter cohort—a work from the ENSAT-PACT working group},
journal = {European Journal of Endocrinology},
year = {2024},
doi = {10.1093/ejendo/lvae079}
}
EUVIMED